Home Policy and Advocacy RCPI Policy Group on Tobacco

RCPI Policy Group on Tobacco

Dr Pat Doorley meets with Mr Micheál Martin

RCPI: Supporting Tobacco Free Ireland

Tobacco is an addictive drug that kills when used as intended.

As a healthcare organisation representing thousands of doctors on the frontline of our health services, we represent a patient-focused, independent voice in the national debate on addressing the harm caused by tobacco.

Members of the RCPI Policy Group on Tobacco are doctors working in the Irish health system, many of whom treat patients with serious cardiovascular and respiratory diseases and cancers caused by smoking.

Our doctors want to take action to prevent more lives being lost by reviewing the latest evidence and proposing practical ways to reduce smoking prevalence in Ireland.

The RCPI Policy Group on Tobacco was established in 2014 and is chaired by Dr Des Cox, Consultant in Paediatric Respiratory Medicine at Our Lady's Children's Hospital, Crumlin.

Dr Pat Doorley, Former Chair of the RCPI Tobacco Policy Group, on controlling the tobacco epidemic

Why Do We Need to Take Action?

Tobacco smoke affects virtually every organ in the body and leads to serious and fatal cardiovascular and respiratory disease as well as lung cancer and other cancers.

As highlighted in the HSE’s successful QUIT campaign, one of every two people who smoke long term will die from a smoking related disease. The average smoker loses about 10 quality years of life because of smoking.

The health impacts however are not only limited to smokers; exposure to secondhand smoke also results in many of the same health risks. Exposure to secondhand smoke from parents compromises the vascular health of children; so much so that the impact is seen up to 25 years later.

There has been much progress in reducing smoking prevalence in Ireland, and the introduction of the workplace smoking ban in 2004 was a pioneering move which was followed by many countries worldwide.

Other measures such as taxation, ban on display at point of sale, and the ban on the sale of cigarettes in packs of less than 20 have been effective, especially in reducing prevalence among children.

However in order to make tobacco addiction a thing of the past, we need sustained commitment not just from the health services and health professionals but also from government and many elements of civil society.

Respiratory Medicine.

What Do We Want?

We want to reduce the prevalence of smoking in Ireland. We want to see the following evidence-based measures introduced:

  •  Implementation of Tobacco Free Ireland

We support the implementation of the Tobacco Free Ireland plan launched by the Minister for Health in 2013. Tobacco Free Ireland was the first policy document to be launched under the Healthy Ireland framework and sets a target for Ireland to be tobacco free (i.e. with a smoking prevalence rate of less than 5%) by the year 2025.

  • A licensing system for the sale of tobacco products

We want to see the introduction of a licensing system for sale of tobacco products, similar to the licensing system that exists for sale of alcohol.

  • Stricter enforcement of tobacco legislation

We want to see stricter enforcement of tobacco legislation and tougher penalties for retailers who break tobacco laws. The current penalties outlined in the Public Health (Tobacco) Act, 2002 are inadequate to deter retailers from breaking legislation. Enhanced resources should also be made available to Environmental Health Officers to ensure enforcement.

  • Publishing of details of retailer outlets in contravention of tobacco sale legislation

We want to see the introduction of legislation to enable the HSE to publish the details of all retail outlets in contravention of tobacco sale legislation, as is currently the case with FSAI closure orders, for example.

  • A ban on sale of electronic cigarettes to children

We want to see a ban on sale of electronic cigarettes to children.

  • Removal of VAT on nicotine replacement patches

We want to see the removal or reduction of VAT on nicotine replacement patches.

  • Price cap regulation on tobacco industry profits

We support the introduction of price cap regulation on tobacco industry profits.

  • A ban on the sale of tobacco products at events/locations primarily intended for persons under 18 years of age

Actions to protect minors from exposure to tobacco products can help to reduce uptake and smoking prevalence among minors. We welcome the prohibition of sale of tobacco products at events/locations primarily intended for persons under 18 years of age.

While we have made much progress in tobacco control in this country in recent years, the toll of tobacco related deaths, disease and disability is still unacceptably high.

RCPI Policy Group on Tobacco

Policy statement 'Towards a Tobacco Free Society', March 2014
Dr Pat Doorley meets with Mr Micheál Martin

Our Publications

Members of the RCPI Policy Group on Tobacco
Dr Des Cox (Chair) Consultant in Paediatric Respiratory Medicine
Prof Tom Clarke Faculty of Paediatrics, RCPI
Dr Linda Coate Irish Society of Medical Oncology
Ms Siobhán Kelly Irish College of Opthamologists
Dr Donal Murray Irish Cardiac Society
Dr Siobhán Nicholson Faculty of Pathology, RCPI
Dr Peter Noone Faculty of Occupational Medicine, RCPI
Dr Anthony O'Regan Irish Thoracic Society
Dr Margaret O'Rourke Psychological Society of Ireland
Dr Ann O'Shaughnessy Head of Education and Professional Development, RCPI
Dr Carmen Regan Institute of Obstetricians & Gynaecologists, RCPI
Dr Peter Wright Faculty of Public Health Medicine, RCPI
 

Contact Us

For information on our policy work on tobacco contact:

Yvonne McCahill

Press Officer, Communications Department

Tel: +353 1 8639 627 | Mobile 086 7723056

For general press enquiries or if you want to speak to a trusted medical expert, contact Yvonne in our Communications Department.

Mairead Heffron

Strategy and Policy Specialist

Tel: +353 1 863 9691

Contact Mairead for information about our policy work in RCPI.